Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Biological Psychiatry
|
June 20, 2024
A Cocaine-Activated Ensemble Exerts Increased Control Over Behavior While Decreasing in Size
Kimberly C Thibeault, Michael Z Leonard, Veronika Kondev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2026
Synaptogyrin-3 plays a critical role in addiction-related dopamine dysfunction and behavioral maladaptations
Emily G Peck, Soren D Emerson, Alyson M Curry, et al.
Molecular Neurodegeneration
|
August 22, 2018
Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease
Mark T W Ebbert, Stefan L Farrugia, Jonathon P Sens, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits
Emily G Peck, Katherine M Holleran, Alyson M Curry, et al.
Genome Biology
|
May 21, 2019
Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
Mark T W Ebbert, Tanner D Jensen, Karen Jansen-West, et al.
Acta Neuropathologica Communications
|
December 2, 2020
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
Aleksandra M Wojtas, Yari Carlomagno, Jonathon P Sens, et al.
JCI Insight
|
May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathology
John Grizzanti, William R Moritz, Morgan C Pait, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Biological Psychiatry
|
June 20, 2024
A Cocaine-Activated Ensemble Exerts Increased Control Over Behavior While Decreasing in Size
Kimberly C Thibeault, Michael Z Leonard, Veronika Kondev, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 12, 2026
Synaptogyrin-3 plays a critical role in addiction-related dopamine dysfunction and behavioral maladaptations
Emily G Peck, Soren D Emerson, Alyson M Curry, et al.
Molecular Neurodegeneration
|
August 22, 2018
Long-read sequencing across the C9orf72 'GGGGCC' repeat expansion: implications for clinical use and genetic discovery efforts in human disease
Mark T W Ebbert, Stefan L Farrugia, Jonathon P Sens, et al.
Biorxiv : the Preprint Server for Biology
|
August 30, 2024
Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits
Emily G Peck, Katherine M Holleran, Alyson M Curry, et al.
Genome Biology
|
May 21, 2019
Systematic analysis of dark and camouflaged genes reveals disease-relevant genes hiding in plain sight
Mark T W Ebbert, Tanner D Jensen, Karen Jansen-West, et al.
Acta Neuropathologica Communications
|
December 2, 2020
Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation
Aleksandra M Wojtas, Yari Carlomagno, Jonathon P Sens, et al.
JCI Insight
|
May 2, 2023
KATP channels are necessary for glucose-dependent increases in amyloid-β and Alzheimer's disease-related pathology
John Grizzanti, William R Moritz, Morgan C Pait, et al.
Page
of 3